Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.2.1.97: endo-alpha-N-acetylgalactosaminidase

This is an abbreviated version!
For detailed information about endo-alpha-N-acetylgalactosaminidase, go to the full flat file.

Word Map on EC 3.2.1.97

Reaction

beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-[glycoprotein]-L-serine/L-threonine
+
H2O
=
beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine
+
[glycoprotein]-L-serine/L-threonine

Synonyms

acetylgalactosaminidase, endo-alpha, D-galactosyl-N-acetyl-alpha-D-galactosamine D-galactosyl-N-acetylgalactosaminohydrolase, EC 3.2.1.110, endo GalNAc-ase S, endo-alpha-acetylgalactosaminidase, endo-alpha-GalNAc-ase, endo-alpha-N-acetylgalactosaminidase, endo-alpha-N-acetylgalactosaminidase S, endo-beta-N-acetylgalactosaminidase, endo-EF, endo-GalNAc-ase S, endoEF, EngBF, EngCP, More, NagBb, SpGH101

ECTree

     3 Hydrolases
         3.2 Glycosylases
             3.2.1 Glycosidases, i.e. enzymes that hydrolyse O- and S-glycosyl compounds
                3.2.1.97 endo-alpha-N-acetylgalactosaminidase

Inhibitors

Inhibitors on EC 3.2.1.97 - endo-alpha-N-acetylgalactosaminidase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
Ag+
-
5 mM, 35% inhibition
C2H5HgCl
-
5 mM, 23% inhibition
CH3HgCl
-
5 mM, 18% inhibition
Co2+
-
5 mM, 18% inhibition
Cr3+
-
5 mM, 58% inhibition
DFP
-
1 mM, 48% inhibition
Fe3+
-
5 mM, 15% inhibition
galactonolactone
-
5 mM, 11% inhibition
glucose
-
5 mM, 11% inhibition
iodoacetate
-
5 mM, 17% inhibition
L-Cys
-
2 mM, 12% inhibition
N-bromosuccinimide
-
1 mM, complete inhibition
p-chloromercuribenzenesulfonate
-
1 mM, 60% inhibition
p-Nitrophenyl-2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-beta-D-galactopyranoside
-
-
PCMB
-
1 mM, 26% inhibition
SDS
-
strong inhibition
sodium deoxycholate
-
slightly effective
Triton X-100
-
slightly effective
Tween 20
-
slightly effective
Tween 80
-
slightly effective
additional information
-